PREMARIN® PATIENT INFORMATION

(conjugated estrogens)

PATIENT INFORMATION

PREMARIN(prem-uh-rin)

(Conjugated estrogen tablets, USP)

Read this PATIENT INFORMATION before you start taking PREMARIN and read what you get each time you refill your PREMARIN prescription. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT PREMARIN (AN ESTROGEN MIXTURE)?

•
Using estrogen-alone may increase your chance of getting cancer of the uterus (womb)
Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find the cause.
•
Do not use estrogen-alone to prevent heart disease, heart attacks, or dementia (decline of brain function)
•
Using estrogen-alone may increase your chances of getting strokes or blood clots
•
Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
Do not use estrogens with progestins to prevent heart disease, heart attacks, strokes, or dementia
•
Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots
•
Using estrogens with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
You and your healthcare provider should talk regularly about whether you still need treatment with PREMARIN

Find PREMARIN® medical information:

Find PREMARIN® medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREMARIN® Quick Finder

Medication Guide

Health Professional Information

PATIENT INFORMATION

PATIENT INFORMATION

PREMARIN(prem-uh-rin)

(Conjugated estrogen tablets, USP)

Read this PATIENT INFORMATION before you start taking PREMARIN and read what you get each time you refill your PREMARIN prescription. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT PREMARIN (AN ESTROGEN MIXTURE)?

•
Using estrogen-alone may increase your chance of getting cancer of the uterus (womb)
Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find the cause.
•
Do not use estrogen-alone to prevent heart disease, heart attacks, or dementia (decline of brain function)
•
Using estrogen-alone may increase your chances of getting strokes or blood clots
•
Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
Do not use estrogens with progestins to prevent heart disease, heart attacks, strokes, or dementia
•
Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots
•
Using estrogens with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
You and your healthcare provider should talk regularly about whether you still need treatment with PREMARIN
Prescribing Information
Download Prescribing Information

Health Professional Information

PATIENT INFORMATION

PATIENT INFORMATION

PREMARIN(prem-uh-rin)

(Conjugated estrogen tablets, USP)

Read this PATIENT INFORMATION before you start taking PREMARIN and read what you get each time you refill your PREMARIN prescription. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT PREMARIN (AN ESTROGEN MIXTURE)?

•
Using estrogen-alone may increase your chance of getting cancer of the uterus (womb)
Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find the cause.
•
Do not use estrogen-alone to prevent heart disease, heart attacks, or dementia (decline of brain function)
•
Using estrogen-alone may increase your chances of getting strokes or blood clots
•
Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
Do not use estrogens with progestins to prevent heart disease, heart attacks, strokes, or dementia
•
Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots
•
Using estrogens with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older
•
You and your healthcare provider should talk regularly about whether you still need treatment with PREMARIN

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.